Hepatocellular carcinoma and intrahepatic cholangiocarcinoma are driven by distinct cancer hallmarks that shape their biology, therapeutic vulnerabilities, and immune interactions. This review explores how this framework has reshaped our understanding of molecular mechanisms and immunotherapy responses, as well as advanced precision medicine in liver cancer.